Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Agilon Health Q2 EPS $(0.25) Misses $(0.12) Estimate, Sales $1.395B Miss $1.472B Estimate

Author: Benzinga Newsdesk | August 04, 2025 05:28pm
Agilon Health (NYSE:AGL) reported quarterly losses of $(0.25) per share which missed the analyst consensus estimate of $(0.12) by 113.68 percent. This is a 257.14 percent decrease over losses of $(0.07) per share from the same period last year. The company reported quarterly sales of $1.395 billion which missed the analyst consensus estimate of $1.472 billion by 5.24 percent. This is a 5.93 percent decrease over sales of $1.483 billion the same period last year.

Posted In: AGL

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist